Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol.

IF 1.7 4区医学 Q3 HEALTH POLICY & SERVICES

Cost Effectiveness and Resource Allocation Pub Date : 2024-04-13 DOI:10.1186/s12962-024-00535-2

Lisa Derendorf, Stephanie Stock, Dusan Simic, Arim Shukri, Christine Zelenak, Jonas Nagel, Tim Friede, Birgit Herbeck Belnap, Christoph Herrmann-Lingen, Susanne S Pedersen, Jan Sørensen, Dirk Müller And On Behalf Of The Escape Consortium

{"title":"Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol.","authors":"Lisa Derendorf, Stephanie Stock, Dusan Simic, Arim Shukri, Christine Zelenak, Jonas Nagel, Tim Friede, Birgit Herbeck Belnap, Christoph Herrmann-Lingen, Susanne S Pedersen, Jan Sørensen, Dirk Müller And On Behalf Of The Escape Consortium","doi":"10.1186/s12962-024-00535-2","DOIUrl":null,"url":null,"abstract":"Background: Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications.Methods: The trial-based economic analyses will include cross-country cost-effectiveness and cost-utility assessments from a payer perspective. The cost-utility analysis will calculate quality-adjusted life years (QALYs) using the EQ-5D-5L and national value sets. Cost-effectiveness will include the cost per hospital admission avoided and the cost per depression-free days (DFD). Resource use will be measured from different sources, including electronic medical health records, standardised questionnaires, patient receipts and a care manager survey. Uncertainty will be addressed using bootstrapping.Discussion: The various methods and approaches used for data acquisition should provide insights into the potential benefits and cost-effectiveness of a BCC intervention. Providing the economic evaluation of ESCAPE will contribute to a country-based structural and organisational planning of BCC (e.g., the number of patients that may benefit, how many care managers are needed). Improved care is expected to enhance health-related quality of life at little or no extra cost.Trial registration: The study follows CHEERS2022 and is registered at the German Clinical Trials Register (DRKS00025120).","PeriodicalId":47054,"journal":{"name":"Cost Effectiveness and Resource Allocation","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11015692/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cost Effectiveness and Resource Allocation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12962-024-00535-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications.

Methods: The trial-based economic analyses will include cross-country cost-effectiveness and cost-utility assessments from a payer perspective. The cost-utility analysis will calculate quality-adjusted life years (QALYs) using the EQ-5D-5L and national value sets. Cost-effectiveness will include the cost per hospital admission avoided and the cost per depression-free days (DFD). Resource use will be measured from different sources, including electronic medical health records, standardised questionnaires, patient receipts and a care manager survey. Uncertainty will be addressed using bootstrapping.

Discussion: The various methods and approaches used for data acquisition should provide insights into the potential benefits and cost-effectiveness of a BCC intervention. Providing the economic evaluation of ESCAPE will contribute to a country-based structural and organisational planning of BCC (e.g., the number of patients that may benefit, how many care managers are needed). Improved care is expected to enhance health-related quality of life at little or no extra cost.

Trial registration: The study follows CHEERS2022 and is registered at the German Clinical Trials Register (DRKS00025120).

查看原文本刊更多论文

针对老年多病心衰患者的混合协作护理的卫生经济评估：研究方案。

背景：综合护理，尤其是 "混合协作护理 (BCC) "策略，有可能在不增加或减少额外费用的情况下，改善多病心力衰竭（HF）患者的健康相关生活质量（HRQoL）。ESCAPE试验是一项随机对照试验，旨在评估欧洲五国的BCC方法。对该试验进行经济评估的四个主要目标是(i) 记录实施干预的成本，(ii) 评估各研究地点的运行成本，(iii) 与提供者的常规护理相比，评估短期成本效益和成本效用，(iv) 研究预算影响：方法：基于试验的经济分析将包括从支付方角度进行的跨国成本效益和成本效用评估。成本效用分析将使用 EQ-5D-5L 和国家价值集计算质量调整生命年 (QALY)。成本效益将包括每次避免入院的成本和每次无抑郁天数（DFD）的成本。资源使用情况将通过不同来源进行测量，包括电子医疗健康记录、标准化问卷、患者收据和护理经理调查。不确定性将通过引导法来解决：讨论：用于获取数据的各种方法和途径应有助于深入了解 BCC 干预措施的潜在效益和成本效益。提供ESCAPE的经济评估将有助于基于国家的BCC结构和组织规划（例如，可能受益的患者人数、需要多少护理管理者）。改善护理有望提高与健康相关的生活质量，而几乎不需要额外费用：该研究遵循 CHEERS2022，已在德国临床试验注册中心（DRKS00025120）注册。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cost Effectiveness and Resource Allocation HEALTH POLICY & SERVICES-

CiteScore

3.40

自引率

4.30%

发文量

审稿时长

34 weeks

期刊介绍： Cost Effectiveness and Resource Allocation is an Open Access, peer-reviewed, online journal that considers manuscripts on all aspects of cost-effectiveness analysis, including conceptual or methodological work, economic evaluations, and policy analysis related to resource allocation at a national or international level. Cost Effectiveness and Resource Allocation is aimed at health economists, health services researchers, and policy-makers with an interest in enhancing the flow and transfer of knowledge relating to efficiency in the health sector. Manuscripts are encouraged from researchers based in low- and middle-income countries, with a view to increasing the international economic evidence base for health.